SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients
The observational results are hypothesis-generating, but more-definitive randomized trial data are coming soon.
Related Articles
Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison
AbstractThis review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society of Cardiology…
Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison
AbstractThis review serves to compare contemporary clinical practice recommendations for the management of heart failure (HF), as codified in the 2021 European Society of Cardiology…
Need a Statin for Primary Prevention? There’s an App for That
The technology is part of a broader push to make rosuvastatin 5 mg available OTC, a push that’s felled other statins before.
Serial direct sodium removal in patients with heart failure and diuretic resistance
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Biologic Winrevair Wins FDA Approval for Treatment of PAH
The injectable activin signaling inhibitor is the first of this class to be approved by the FDA and is meant to be given every 3…
Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease
Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease
RYR2 Variant and Sudden Death in Patients With Dilated Cardiomyopathy:
Cardiovascular Clinical Academic Group, St George’s University Hospitals NHS Foundation Trust, London, United Kingdom Cardiovascular and Genomics Research Institute, St George’s University of London, London,…